Commission Offers Glimpse Of Actions To Speed Up MDR Compliance
Executive Summary
With a sense of desperation building among stakeholders over the challenges in ensuring all products are compliant with the Medical Device Regulation in time, high-level solutions are being considered. But a further MDR delay is not an option.
You may also be interested in...
Will Commission heed COCIR’s Comprehensive And Sometimes Radical Solutions To MDR Delays?
Industry’s timely compliance with the EU’s new medtech regulations is under threat. Will the European Commission consider potential solutions from COCIR as a persuasive factor for change?
European Regulatory Roundup, November 2022: EU MDR Situation Now Critical
Damage limitation action is expected imminently to try and stem the flow of medtech products being taken off the EU market. And it cannot come quickly enough as evidence continues to mount of the negative fall-out resulting from the way the EU’s new medical device regulations have been, and are being, implemented.
EU Designates First Czech Notified Body Under MDR
The latest notified body listing brings total number of EU designated Medical Device Regulation testing and certification organizations to 35.